Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies.

Molecular and cellular biochemistry - 1 Jan 2018

Kumar Amit, Rani Bindu, Sharma Rajni, Kaur Gurjeet, Prasad Rishikesh, Bahl Ajay, Khullar Madhu

Abstract excerpt

The marked clinical and genetic heterogeneity seen in hypertrophic (HCM) and dilated cardiomyopathies (DCM) suggests involvement of disease modifiers and environmental factors in the pathophysiology of these diseases. In the current study, we examined association of single nucleotide polymorphisms (SNPs) of three candidate genes, ACE2 (rs6632677), TNNI3K (rs49812611) and CALM3 (rs13477425) with clinical...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to Calmodulin
Share to Cardiomyopathy, Dilated
Share to Cardiomyopathy, Hypertrophic
Share to MAP Kinase Kinase Kinases
Share to Peptidyl-Dipeptidase A
Share to Protein Serine-Threonine Kinases
Share to Risk Factors

Source

Identifiers

PMID: 28744816
DOI: 10.1007/s11010-017-3123-9

Genes

ACE2
CALM3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies.PMID 28744816Read ↗

Genetic polymorphism of angiotensin-converting enzyme and hypertrophic cardiomyopathy risk: A systematic review and meta-analysis.Semantic proximity Read ↗

Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Impact of angiotensin I converting enzyme insertion/deletion polymorphisms on dilated cardiomyopathy and hypertrophic cardiomyopathy risk.Semantic proximity Read ↗

The role of genetic variants in angiotensin I converting enzyme, angiotensinogen and the angiotensin II type-1 receptor in the pathophysiology of heart muscle disease.Semantic proximity Read ↗

Role of common sarcomeric gene polymorphisms in genetic susceptibility to left ventricular dysfunction.Semantic proximity Read ↗

Genetic Association of the Ins/Del Variant of ACE and Risk of Cardiomyopathy: A Case-Control Study and Updated Meta-Analysis.Semantic proximity Read ↗

The influence of Angiotensin converting enzyme and angiotensinogen gene polymorphisms on hypertrophic cardiomyopathy.Semantic proximity Read ↗

Polymorphisms of beta-adrenoceptor and natriuretic peptide receptor genes influence the susceptibility to and the severity of idiopathic dilated cardiomyopathy in a Chinese cohort.Semantic proximity Read ↗

High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians.Semantic proximity Read ↗

Modifier genes for hypertrophic cardiomyopathy.Semantic proximity Read ↗

Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy.Semantic proximity Read ↗

ACE I/D polymorphism in Indian patients with hypertrophic cardiomyopathy and dilated cardiomyopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.